Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice.

IF 14.3 1区医学 Q1 CELL & TISSUE ENGINEERING Bone Research Pub Date : 2023-05-06 DOI:10.1038/s41413-023-00266-9

Silvia Marino, Nisreen Akel, Shenyang Li, Meloney Cregor, Meghan Jones, Betiana Perez, Gaston Troncoso, Jomeeka Meeks, Scott Stuart, Amy Y Sato, Intawat Nookaew, Teresita Bellido

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

作者更正:在小鼠中使用合成代谢疗法逆转糖尿病骨特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Bone Research CELL & TISSUE ENGINEERING-

CiteScore

20.00

自引率

4.70%

发文量

289

审稿时长

20 weeks

期刊介绍： Established in 2013, Bone Research is a newly-founded English-language periodical that centers on the basic and clinical facets of bone biology, pathophysiology, and regeneration. It is dedicated to championing key findings emerging from both basic investigations and clinical research concerning bone-related topics. The journal's objective is to globally disseminate research in bone-related physiology, pathology, diseases, and treatment, contributing to the advancement of knowledge in this field.

期刊最新文献

IRF1-mediated upregulation of PARP12 promotes cartilage degradation by inhibiting PINK1/Parkin dependent mitophagy through ISG15 attenuating ubiquitylation and SUMOylation of MFN1/2. Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect Osteopetrosis-like disorders induced by osteoblast-specific retinoic acid signaling inhibition in mice A monoallelic variant in CCN2 causes an autosomal dominant spondyloepimetaphyseal dysplasia with low bone mass Periostin+ myeloid cells improved long bone regeneration in a mechanosensitive manner